Depression in epilepsy, migraine, and multiple sclerosis
Epidemiology and how to screen for it
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 30, 2016
- Accepted February 7, 2017
- First Published March 24, 2017.
Article Versions
- Previous version (March 24, 2017 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Nathalie Jetté, MD, MSc,
- Farnaz Amoozegar, MD, MSc and
- Scott B. Patten, MD, PhD
- Nathalie Jetté, MD, MSc,
NONE
NONE
NONE
Epilepsia, Associate Editor, 2013 to present; Neurology Editorial Board since 2015.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) I was a co-investigator on an operating grant from the University of Calgary Hotchkiss Brain Institute, co- funded by Pfizer Canada for work not related to this paper.
Role for all of these is principal investigator or co- principal investigator (and these grants are not related to the current study): Canada Research Chair Tier 2 in Neuroscience Health Services Research, salary support (2010-present); Canadian Institutes for Health Research (2007 to present).
NONE
Alberta Spine Foundation (2015-2016), Alberta Health, Hotchkiss Brain Institute (operating funds 2015-present); Cumming School of Medicine at the University of Calgary (operating funds 2016-present).
NONE
NONE
NONE
NONE
NONE
NONE
- Farnaz Amoozegar, MD, MSc and
NONE
NONE
1) Allergan - speaker's honoraria 2) Tribute pharmaceuticals - speaker's honoraria 3) Teva - conference travel and accommodations 4) EMD Serono - speaker's honoraria 5) Aralez - speaker's honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) Eli Lilly - sponsorship of clinical trials - no direct funds to me 2) Teva - sponsorship of clinical trials - no direct funds to me 3) Amgen - sponsorship of clinical trials - no direct funds to me 4) Allergan
NONE
1) University of Calgary Clinical Research Fund for registry research 2) University of Calgary Clinical Research Fund for observational study
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Scott B. Patten, MD, PhD
NONE
NONE
NONE
(1) Canadian Journal of Psychiatry, Editor-in-Chief, 2014-present. (2) Chronic Diseases in Canada, Editorial Advisory Board Member, 2009-present. (3) Clinical Practice and Epidemiology in Mental Health, Editorial Advisory Board Member, 2010-present. (4) Sr. Assoc. Editor, Epidemiology & Psychiatric Sciences
NONE
Epidemiology for Canadian Students. Brush Education, 2015.
NONE
NONE
NONE
NONE
NONE
NONE
(1) Canadian Institutes for Health Research, MOP-89816, P.I. 2008-2011 and MOP-130415, P.I. 2013-2015. (2) Hotchkiss Brain Institute. Depression in the Community, 2013-2016. (3) Hotchkiss Brain Institute/Pfizer Research Competition. Building a Foundation for a Depression eHub for Neurological Patients, 2015 - 2016.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Clinical Neurosciences (NJ, FA), Hotchkiss Brain Institute (NJ, FA, SBP), Department of Psychiatry (SBP), Mathison Health Centre (SBP), Department of Community Health Sciences (NJ, FA, SBP), and O'Brien Institute for Public Health (NJ, FA, SBP), Cumming School of Medicine, University of Calgary, Canada.
- Correspondence to:
nathalie.jette{at}albertahealthservices.ca
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Views & Reviews
Detecting depression in Parkinson diseaseA systematic review and meta-analysisZahra Goodarzi, Kelly J. Mrklas, Derek J. Roberts et al.Neurology, June 29, 2016 -
Research
Validity of the Patient Health Questionnaire-9 in neurologic populationsKimberly G. Williams, Michael Sanderson, Nathalie Jette et al.Neurology: Clinical Practice, October 23, 2019 -
Article
Prevalence of lifetime depression in a large hemiplegic migraine cohortMark A. Louter, Nadine Pelzer, Irene de Boer et al.Neurology, November 02, 2016 -
Review
Psychiatric Comorbidities in People With EpilepsyMarco Mula, Andres M. Kanner, Nathalie Jetté et al.Neurology: Clinical Practice, May 29, 2020